Human dermal microvascular endothelial cells (HDMEC) are strategically located to play an important role in the cutaneous inflammatory response. Because of the difficult in growing these cells in pure culture, little is known about their functions in inflammatory skin diseases. This laboratory has recently succeeded in isolating and culturing pure HDMEC from neonatal foreskins. These HDMEC can be expanded to large cell numbers and used in functional studies. In addition, this laboratory recently succeeded in inducing both human umbilical vein endothelial cells (HUVE) and HDMEC to undergo extremely rapid differentiation in vitro. The differentiated endothelial cells become elongated and form tubes with lumina that resemble microvessels in vivo. We will systematically study the role of microvascular endothelial cells in cutaneous inflammation and define the signals that induce endothelial cell differentiation. Studies in this proposal will characterize the immunologically relevant cell surface receptors and antigens, as well as cell adhesion molecules present on differentiated and undifferentiated HDMEC, in order to gain insights into the potential immunologic functions of these cells. The ability of biologic response modifiers to induce or modulate the expression of these molecules will be precisely defined. This proposal will assess the ability of purified human T-lymphocytes and monocytes to bind to undifferentiated and differentiated HDMEC and HUVE to delineate the mechanisms of leukocyte- endothelial cell interaction. The subpopulations of T-cells that bind will also be defined. In addition, the cell adhesion molecules responsible for T-cell and monocyte adherence to HDMEC will be defined using specific monoclonal antibodies directed against T-cell, monocyte, and endothelial cell adherence molecules. The ability of commonly used therapeutic modalities such as corticosteroids, and ultraviolet light to affect expression of cell adhesion molecules and cell-cell adherence will be systematically assessed. Related studies in this proposal will utilize cytotoxicity assays to assess the presence of antiendothelial cell antibodies in sera of patients with cutaneous and/or systemic vasculitis. The cell surface molecules bound by the antiendothelial cell antibodies will be immunoprecipitated and analyzed immunochemically. Thus, the studies in this proposal will provide new and important insights into the initiation and evolution of cutaneous inflammation and have direct bearing on the pathophysiology of inflammatory skin diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR039632-04
Application #
3159823
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1989-01-01
Project End
1993-12-31
Budget Start
1992-01-01
Budget End
1992-12-31
Support Year
4
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Emory University
Department
Type
Schools of Medicine
DUNS #
042250712
City
Atlanta
State
GA
Country
United States
Zip Code
30322
Gira, Amy K; Kowalczyk, Andrew P; Feng, Yue et al. (2009) Iron chelators and hypoxia mimetics inhibit IFNgamma-mediated Jak-STAT signaling. J Invest Dermatol 129:723-9
O'Reilly, Fiona M; Casper, Katherine A; Otto, Kristen B et al. (2003) Regulation of tissue factor in microvascular dermal endothelial cells. J Invest Dermatol 120:489-94
Gira, Amy K; Casper, Katherine A; Otto, Kristen B et al. (2003) Induction of interferon regulatory factor 1 expression in human dermal endothelial cells by interferon-gamma and tumor necrosis factor-alpha is transcriptionally regulated and requires iron. J Invest Dermatol 121:1191-6
Koo, Sang-Wahn; Casper, Katherine A; Otto, Kristen B et al. (2003) Iron chelators inhibit VCAM-1 expression in human dermal microvascular endothelial cells. J Invest Dermatol 120:871-9
Gille, J; Paxton, L L; Lawley, T J et al. (1997) Retinoic acid inhibits the regulated expression of vascular cell adhesion molecule-1 by cultured dermal microvascular endothelial cells. J Clin Invest 99:492-500
Gille, J; Swerlick, R A; Lawley, T J et al. (1996) Differential regulation of vascular cell adhesion molecule-1 gene transcription by tumor necrosis factor alpha and interleukin-1 alpha in dermal microvascular endothelial cells. Blood 87:211-7
Xu, Y; Swerlick, R A; Sepp, N et al. (1994) Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J Invest Dermatol 102:833-7
Swerlick, R A; Lee, K H; Wick, T M et al. (1992) Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. J Immunol 148:78-83